BOTOX Cosmetic® | Auburn, AL
According to the American Society of Plastic Surgeons, 7.7 million botulinum toxin type A procedures were performed in 2019 in the United States! This makes it the most popular cosmetic procedure in the country.
What does BOTOX ® do?
- Relax facial muscles to reduce wrinkles.
- Relax the muscles that pull the eyebrow down which can result in an elevation of the brow.
Where is BOTOX ® used?
- Between the eyebrows (glabella or 11s)
- Forehead *
- Crow’s feet
- Nose *
- Upper lip * (lip flip or smokers lines)
- Corner of the mouth * (DAO)
- Jaw line or masseter muscle *
- Chin dimpling *
- Neck bands *
- Palms, soles of feet, and underarms for excessive sweating* More info.
*BOTOX ® is approved for the treatment of glabella lines and crow’s feet by the FDA. All other treatments are considered “off-label.” The photos above are models, not actual patients of Dr. Aquadro.
Who is not a candidate for BOTOX ®?
- Pregnant or nursing women
- Sensitivities to human albumin, aminoglycoside antibiotics or BOTOX®
- Neuromuscular disorders (ALS, myasthenia gravis, Lambert-Eaton Syndrome, etc.)
What can I expect after BOTOX ® treatment?
BOTOX® Cosmetic treatment has minimal to no downtime. The most common side effect is some redness at the site of injection or mild bruising. Most people return to normal activity immediately following treatment. Dr. Aquadro recommends that you refrain from strenuous activity for 24hrs following injection. The effects of the treatment will not take effect until 4 to 5 days after injection and the full result may not be realized until two weeks following treatment. The effects of BOTOX ® Cosmetic generally last between three and four months.
Indications: BOTOX® Cosmetic is a prescription medicine that is injected into muscles and used to temporarily improve the look of moderate to severe forehead lines, crow’s feet lines, and frown lines between the eyebrows in adults.
WARNING: DISTANT SPREAD OF TOXIN EFFECT | Postmarketing reports indicate that the effects of BOTOX® Cosmetic and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have an underlying condition that would predispose them to these symptoms. In unapproved uses, including spasticity in children, and in approved indications, cases of spread of effect have been reported at doses comparable to those used to treat cervical dystonia and upper limb spasticity and at lower doses.